Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    28-August-2000      
Issue 137 Next Update - 14:00 UTC 08:00 EST    29-August-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya

Back To Vidyya Today In Vidyya sm

Newsletter Summary For 28-August-2000:

The U.S. Food and Drug Administration (FDA) has approved the first and only asthma medication that simultaneously treats both of the underlying components of the disease: inflammation and bronchoconstriction. The drug will be marketed under the name Advair Diskus ® (fluticasone propionate and salmeterol inhalation powder). The new Glaxo Wellcome medication will offer many asthma patients an effective and convenient approach to treating their condition, improving their lung function and helping control their symptoms.

The science used in combining the drugs that make up Advairtm came from a publication from the National Heart, Lung and Blood Institute (NHLBI). This issue contains the publication. The Practical Guide for the Diagnosis and Management of Asthma describes how primary care clinicians can improve the asthma care they provide within the time constraints of their current clinical practice. More than 130 primary care professionals reviewed this guide to help assure that it is relevant and practical for primary care practitioners.

A South African newpaper reported on Saturday that more than 50 physicians are accused of testing people for HIV without their knowledge or consent--and then passing on the result to the patients' employer. Most patients did not receive counseling before or after the test, the group said, adding that in some cases, test results were sent directly to the employer and the patient was not informed about the result.

In other news, an alarming number of osteoporosis patients are not getting proper follow-up care to confirm the real cause of their disease, according to a recent study conducted by the Department of Endocrinology and Diabetes, at Newton-Wellesley Hospital in Newton, Massachusetts. This means many of these patients may not be getting proper treatment.

An estimated 1.3 million osteoporosis-related fractures occur each year in the U.S. About 70% of fractures in persons aged 45 or older are types that are related to osteoporosis. The task of screening and follow-up for the osteoporosis patient can be difficult. This issue includes screening recommendations from the US government to help practitioners be prepared.

The articles in today's Vidyya are:

As always, we hope you enjoy the issue.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.